Literature DB >> 29141218

Reciprocal Expression of IL-35 and IL-10 Defines Two Distinct Effector Treg Subsets that Are Required for Maintenance of Immune Tolerance.

Xundong Wei1, Jianhua Zhang2, Qianchong Gu1, Man Huang1, Wei Zhang2, Jie Guo2, Xuyu Zhou3.   

Abstract

Regulatory T cells (Tregs) can exert their functions through multiple suppressive mechanisms; however, it is unclear how Tregs exactly employ these mechanisms. In this study, we found that interleukin-35 (IL-35)-producing Tregs were a distinct effector population from the IL-10-producing subset. We also revealed that these two subsets of effector Tregs have different transcription factor dependency. Terminal differentiation regulator Blimp1 was only critical for IL-10 production, but not for IL-35; Foxp3 was essential for IL-35 but dispensable for IL-10 production. Furthermore, we demonstrated that IL-35-producing and IL-10-producing Tregs have a different activation status, do not share the same geographic locations in secondary lymphoid organs, and work in a complementary way to prevent autoimmunity. Thus, our study highlights the importance of effector Treg generation. We also provide evidence of Treg activation status tuning the generation of distinct effector Treg subsets, which work cooperatively to maintain immune tolerance.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blimp1; Foxp3; effector Treg; interleukin 10; interleukin 35

Mesh:

Substances:

Year:  2017        PMID: 29141218     DOI: 10.1016/j.celrep.2017.10.090

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  49 in total

Review 1.  Interleukin-35 in immune-related diseases: protection or destruction.

Authors:  Junfeng Zhang; Yunsheng Zhang; Qingpeng Wang; Chunlei Li; Hongxin Deng; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-03-07       Impact factor: 7.397

2.  DNMT1-mediated Foxp3 gene promoter hypermethylation involved in immune dysfunction caused by arsenic in human lymphocytes.

Authors:  Yemei Ma; Ying Ye; Yining Liu; Jing Chen; Yanli Cen; Wenyan Chen; Chun Yu; Qibing Zeng; Aihua Zhang; Guanghong Yang
Journal:  Toxicol Res (Camb)       Date:  2020-08-06       Impact factor: 3.524

3.  Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis.

Authors:  Samuel S Duffy; Brooke A Keating; Chamini J Perera; Justin G Lees; Ryan S Tonkin; Preet G S Makker; Pascal Carrive; Oleg Butovsky; Gila Moalem-Taylor
Journal:  J Neurosci       Date:  2019-01-16       Impact factor: 6.167

Review 4.  Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.

Authors:  Hiroshi Yano; Lawrence P Andrews; Creg J Workman; Dario A A Vignali
Journal:  Immunology       Date:  2019-06-03       Impact factor: 7.397

Review 5.  Stem cell-based treatment of kidney diseases.

Authors:  Binbin Pan; Guoping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-11

Review 6.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

7.  Cutting Edge: Inhibition of Glycogen Synthase Kinase 3 Activity Induces the Generation and Enhanced Suppressive Function of Human IL-10+ FOXP3+-Induced Regulatory T Cells.

Authors:  Hao Cheng; Lingbiao Wang; Biaolong Yang; Dan Li; Xiaoxia Wang; Xinnan Liu; Na Tian; Qianru Huang; Ru Feng; Zhengting Wang; Rui Liang; Sheng-Ming Dai; Ling Lv; Ji Wu; Yuan-Sheng Zang; Bin Li
Journal:  J Immunol       Date:  2020-08-19       Impact factor: 5.422

8.  MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.

Authors:  Eros Di Giorgio; Liqing Wang; Yan Xiong; Tatiana Akimova; Lanette M Christensen; Rongxiang Han; Arabinda Samanta; Matteo Trevisanut; Tricia R Bhatti; Ulf H Beier; Wayne W Hancock
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

9.  Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.

Authors:  X Liu; H Ren; H Guo; W Wang; N Zhao
Journal:  Clin Exp Immunol       Date:  2020-10-26       Impact factor: 4.330

10.  BATF Regulates T Regulatory Cell Functional Specification and Fitness of Triglyceride Metabolism in Restraining Allergic Responses.

Authors:  Chengxian Xu; Yongyao Fu; Sheng Liu; Jack Trittipo; Xiaoyu Lu; Rong Qi; Hong Du; Cong Yan; Chi Zhang; Jun Wan; Mark H Kaplan; Kai Yang
Journal:  J Immunol       Date:  2021-04-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.